New 'candy' e-cigs catch fire after U.S. regulators stamp out Juul's
flavors
Send a link to a friend
[August 16, 2022] By
Chris Kirkham, Arriana McLymore and Gigi Zamora
RALEIGH, N.C. (Reuters) - Since 2016, the
U.S. Food and Drug Administration has sought to crack down on fruity,
sweet-flavored e-cigarettes that hook teenagers on nicotine.
But at least 20 brands continue to sell China-made disposable devices
with kid-friendly flavors such as "peach blueberry candy" and “pineapple
strawnana" at liquor stores, smoke shops and convenience stores in the
United States, Reuters has found.
Flavored disposable vaping devices account for one-third of U.S.
e-cigarette sales, up from less than 2% three years ago, according to a
Reuters review of retail sales data. Their surge raises questions about
the public health agency’s failure to rein in the booming flavored
e-cigarette market and its ability to enforce its own rules, some
critics say.
Findings by Reuters are drawn from a dataset produced by IRI, a Chicago
market research firm that uses scanner data and other information to
track retail purchases. The IRI dataset, which measures purchases from
Jan. 12, 2014, to June 12, 2022, provides a rare look at the rise of
disposable flavored-nicotine devices following the FDA’s crackdown on
Juul Labs Inc, 35%-owned by Marlboro maker Altria Group Inc.
The data shows for the first time that consumers spent more than $2
billion on the new generation of disposable e-cigarettes over the past
year, surpassing Juul's once-leading market share by about 3 percentage
points since March.
The data was shared with Reuters by an individual outside IRI, who
declined to be identified. An IRI spokesperson said the company is
"unable to confirm any information you’ve received from an outside
source" and that the figures should not be attributed to IRI. According
to a 2019 IRI press release, IRI measures purchases at retailers
including more than 30,000 convenience stores.
The FDA said in written responses to questions that it is “deeply
committed to addressing the ongoing public health concerns around youth
e-cigarette use” and “is constantly monitoring the changing
marketplace.” (Graphic: https://tmsnrt.rs/3zNHvXP)
The FDA in January 2020 banned all flavors except tobacco and menthol in
Juul and other cartridge-based e-cigarettes. In June, it sought to ban
the sale of all Juul e-cigarettes. The agency has since put its order on
hold, saying "there are scientific issues unique to the Juul application
that warrant additional review.”
Juul referred Reuters to previous statements saying it wants no underage
consumers to use its products and that it looks forward to "re-engaging
with the FDA" while the ban is on hold.
Sweet-flavored, disposable e-cigarettes began flooding the market in
2020, trying to capitalize on the former popularity of Juul's
cartridge-based device. Both varieties vaporize a liquid that contains
nicotine, the addictive chemical that gives smokers a rush. Both contain
roughly equal concentrations of nicotine.
Disposable devices, which are pre-filled and priced at $15 to $25, can
have five to 20 times the amount of liquid as a Juul cartridge, based on
visits Reuters made to nine retailers selling both. Some products
advertise that a user can take thousands of puffs of a single device. In
contrast, a Juul, priced at roughly $10, requires users to add separate
cartridges, or pods, of nicotine-laced liquid, priced at $20 to $25 per
four-pack.
MILLIONS SPENT WEEKLY ON TOP SELLERS
Three brands - Kangvape Onee Stick, Esco Bars and Breeze Smoke Breeze
Pro - rang up weekly sales of more than $3 million apiece as of June 12,
according to the data.
Representatives of Esco Bars and Breeze Smoke said their products
contain synthetic nicotine, a version of the addictive drug that is not
derived from tobacco plants and was not under FDA's jurisdiction until
Congress acted earlier this year. Both companies told Reuters they
applied for FDA authorization in 2022.
The FDA declined to disclose the names of synthetic nicotine products
that applied.
Darrell Suriff, CEO at Pastel Cartel, the Texas company that makes Esco
Bars, said it spent nearly $3 million preparing applications to the FDA.
Firms like his that try to follow the rules should not be penalized, he
said: "There's a lot of bad players in the industry ... We're not one of
them."
[to top of second column] |
Flavored disposable e-cigarettes are
seen in this illustration taken July 18, 2022. REUTERS/Shannon
Stapleton
Jon Glauser, chief strategy officer for Hyde, in Buffalo, New York, another
disposable brand with synthetic nicotine and sales of nearly $3 million per
week, said he understands critics' concerns that sweet-flavored e-cigarettes
appeal to teens, potentially addicting them. But adults "really do like
flavors," he said.
Representatives at privately held Shenzhen Kangvape Technology Co did not
respond to requests for comment.
FILLING A 'SWEET' VOID
Juul popularized e-cigarettes among teenagers starting in 2017. Juul's cachet
with teens faded after 2019 when it pulled mango, mint and fruit flavors under
regulatory pressure, leaving room for dozens of other brands to step in. As
sales of flavored disposable devices have soared, Juul's U.S. market share fell
to about 30%, from more than 70% in 2018 and 2019, according to the data.
At Luxury Tobacco & Vape in Raleigh, North Carolina, a display for disposable
Elf Bar recently offered more than a dozen flavors such as sour apple and
rainbow candy. Juul occupied just a fraction of the shelf. Juul declined to
comment on the display. Elf Bar did not respond to requests for comment.
According to FDA rules, e-cigarettes cannot be sold in the United States unless
their makers submitted scientific applications by September 2020 demonstrating
why their products benefit public health. E-cigarettes containing synthetic
nicotine had until May 14, 2022, to apply.
Reuters provided the FDA with a list of more than two-dozen flavored devices
that the news agency found in stores and online, even though they were not on an
FDA list of products that filed applications by 2020. (Graphic: https://tmsnrt.rs/3Qcf7nq)
The FDA declined to answer questions about whether the products Reuters
identified had applied for the required authorizations.
An FDA spokesperson pointed to the agency's website, which stated: "Our
compliance and enforcement work is a multi-step process that cannot happen
overnight."
Mitch Zeller, who retired in April as the director of FDA's tobacco unit, told
Reuters there could be gaps on its list because the FDA needed cooperation from
applicants in order to publicly list them.
"Is FDA going to catch every single violation of the statute? No," Zeller said,
though he said targeting manufacturers that have not applied is FDA's "number
one priority."
The agency said on its website on Aug. 3 that "it is illegal" to sell any
e-cigarettes using synthetic nicotine without its authorization. As of Aug. 15,
the FDA had not granted authorization to any of them.
SEIZURES
Alex Morrin, 19, used Juul starting in 2017 when he was a high school freshman
in the Tampa, Florida, area, drawn to its “fruit,” “creme” and “mint” flavors.
After Juul eliminated those flavors, Morrin began buying fruity, sweet-flavored
disposable e-cigarettes, such as Cali Plus and HQD Cuvie Plus, made by Cali Pods
and HQD Tech USA, both based in Florida. “They just tasted better, and there
were more flavors,” he said. “They’re still all out there, and easy to get.”
Cali Pods and HQD did not respond to requests for comment.
After he began using e-cigarettes, he suffered headaches and nausea, then
seizures that sent him to the hospital six times between January 2020 and last
November. Morrin and his mother, Winna Morrin, said he had never experienced
seizures before his e-cigarette addiction. Winna Morrin provided hospital
records corroborating the seizures. Researchers have established no definitive
link between vaping and seizures.
The FDA told Reuters it is seeking to understand whether the devices' "nicotine
content or formulation may contribute to seizures." Most reports of seizures
from e-cigarettes come from youth, or young adult, users, the FDA said.
(Reporting by Chris Kirkham in Los Angeles, Arriana McLymore in Raleigh, N.C.,
and Gigi Zamora in New York; Additional reporting by Uday Sampath Kumar in
Bengaluru; Editing by Vanessa O'Connell and Matthew Lewis)
[© 2022 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |